- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
National sponsor of the Motherisk Program
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Sept.
5
2013
St. John's,NL
2013 FACE meeting
June
23
2013
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Consortium of Cancer in Pregnancy Evidence (CCoPE)
Arieh Lalkin, MDSenior Physician, Emergency Dept. Kfar Saba Hospital, Israel
Dr. Lalkin is an internist with special interest and training in clinical toxicology and emergency medicine. He has done studies on drugs in pregnancy and drug overdoses in pediatric and adult emergency cases. Dr. Lalkin has served as a consultant to the Ontario Poison Control Center. He is currently senior physician in the emergency department, Kfar Saba Hospital, and also a part of the hospital's emergency toxicology and pharmacology units.
Cancer In Pregnancy Website Article:
Management Of Complications Associated With Cancer Or Antineoplastic Treatment During Pregnancy
![[Valid RSS]](/images/rssValid.png "Validate my RSS feed")